Posted in | News | Gold

Dalradian Resources Extends High Grade Zone in T17 Vein at Curraghinalt Gold Deposit

Dalradian Resources Inc. (TSX:DNA)(TSX:DNA.WT) has successfully extended a high grade zone in the T17 vein 85 metres vertically below the exploration adit at its Curraghinalt gold deposit in Northern Ireland.

Infill hole 10-CT-73 intercepted a true width of 1.83 metres grading 37.41 g/t gold. In addition, further drill holes targeting the Bend and Crow veins have intercepted true widths of 1.52 metres grading 27.05 g/t gold and 0.51 metres grading 18.66 g/t gold respectively. Neither the Bend nor the Crow, referred to in Dalradian's News Release No. 6 dated October 14, 2010, are included in the NI 43-101 technical report dated May 10, 2010.

"These results demonstrate the presence of more high grade mineralization associated with the T17 vein that we intend to follow to depth," said Patrick F. N. Anderson, Dalradian's chairman and chief executive officer. "Moreover, results from the Bend and the Crow veins illustrate the potential to find new mineralized veins not included in the existing resource estimate."

Qualified Person

Vaughan Williams, P. Geo, Eur. Geol., Project Manager, Aurum Exploration Services, a consultant to the Company, is the Qualified Person who supervised the preparation of the technical data in this news release.

Source:

Dalradian Resources Inc.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.